Massachusetts Financial Services Co. MA Sells 1,146,436 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Massachusetts Financial Services Co. MA trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 47.4% in the first quarter, according to its most recent filing with the SEC. The firm owned 1,271,662 shares of the company's stock after selling 1,146,436 shares during the period. Massachusetts Financial Services Co. MA owned approximately 0.77% of Option Care Health worth $44,445,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its holdings in shares of Option Care Health by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after acquiring an additional 344,875 shares during the period. Compass Wealth Management LLC lifted its holdings in shares of Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after acquiring an additional 13,600 shares during the period. Bessemer Group Inc. lifted its holdings in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after acquiring an additional 599 shares during the period. Principal Financial Group Inc. lifted its holdings in Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock valued at $16,981,000 after purchasing an additional 6,616 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after purchasing an additional 1,691 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

Shares of NASDAQ OPCH traded down $0.46 during trading on Friday, reaching $29.48. The company had a trading volume of 954,581 shares, compared to its average volume of 1,828,047. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $4.83 billion, a PE ratio of 23.77, a PEG ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54. The business's 50 day moving average price is $31.62 and its 200-day moving average price is $31.57.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the previous year, the firm posted $0.26 earnings per share. The company's revenue was up 16.3% on a year-over-year basis. Analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Upgrades and Downgrades

OPCH has been the subject of several analyst reports. JMP Securities reissued a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a report on Wednesday, June 18th. Barrington Research reissued an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.